BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 27888226)

  • 1. Single-cell sequencing maps gene expression to mutational phylogenies in PDGF- and EGF-driven gliomas.
    Müller S; Liu SJ; Di Lullo E; Malatesta M; Pollen AA; Nowakowski TJ; Kohanbash G; Aghi M; Kriegstein AR; Lim DA; Diaz A
    Mol Syst Biol; 2016 Nov; 12(11):889. PubMed ID: 27888226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response.
    Szerlip NJ; Pedraza A; Chakravarty D; Azim M; McGuire J; Fang Y; Ozawa T; Holland EC; Huse JT; Jhanwar S; Leversha MA; Mikkelsen T; Brennan CW
    Proc Natl Acad Sci U S A; 2012 Feb; 109(8):3041-6. PubMed ID: 22323597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-34a repression in proneural malignant gliomas upregulates expression of its target PDGFRA and promotes tumorigenesis.
    Silber J; Jacobsen A; Ozawa T; Harinath G; Pedraza A; Sander C; Holland EC; Huse JT
    PLoS One; 2012; 7(3):e33844. PubMed ID: 22479456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGFR signaling in the HGG-02 glioblastoma cell line with an unusual loss of EGFR gene copy.
    Skoda J; Neradil J; Zitterbart K; Sterba J; Veselska R
    Oncol Rep; 2014 Jan; 31(1):480-7. PubMed ID: 24270553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGF/EGFR upregulates and cooperates with Netrin-4 to protect glioblastoma cells from DNA damage-induced senescence.
    Li L; Huang Y; Gao Y; Shi T; Xu Y; Li H; Hyytiäinen M; Keski-Oja J; Jiang Q; Hu Y; Du Z
    BMC Cancer; 2018 Dec; 18(1):1215. PubMed ID: 30514230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic long noncoding RNA LINC02283 enhances PDGF receptor A-mediated signaling and drives glioblastoma tumorigenesis.
    Goenka A; Song X; Tiek D; Iglesia RP; Lu M; Zeng C; Horbinski C; Zhang W; Hu B; Cheng SY
    Neuro Oncol; 2023 Sep; 25(9):1592-1604. PubMed ID: 36988488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of growth factors and their receptors in human esophageal carcinomas: regulation of expression by epidermal growth factor and transforming growth factor alpha.
    Yoshida K; Kuniyasu H; Yasui W; Kitadai Y; Toge T; Tahara E
    J Cancer Res Clin Oncol; 1993; 119(7):401-7. PubMed ID: 8491760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of EGFR and EGFRvIII signaling networks in human glioblastoma tumor xenografts.
    Johnson H; Del Rosario AM; Bryson BD; Schroeder MA; Sarkaria JN; White FM
    Mol Cell Proteomics; 2012 Dec; 11(12):1724-40. PubMed ID: 22964225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olig2-Dependent Reciprocal Shift in PDGF and EGF Receptor Signaling Regulates Tumor Phenotype and Mitotic Growth in Malignant Glioma.
    Lu F; Chen Y; Zhao C; Wang H; He D; Xu L; Wang J; He X; Deng Y; Lu EE; Liu X; Verma R; Bu H; Drissi R; Fouladi M; Stemmer-Rachamimov AO; Burns D; Xin M; Rubin JB; Bahassi EM; Canoll P; Holland EC; Lu QR
    Cancer Cell; 2016 May; 29(5):669-683. PubMed ID: 27165742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive prognostic signature for glioblastoma patients based on transcriptomics and single cell sequencing.
    Fan F; Zhang H; Dai Z; Zhang Y; Xia Z; Cao H; Yang K; Hu S; Guo Y; Ding F; Cheng Q; Zhang N
    Cell Oncol (Dordr); 2021 Aug; 44(4):917-935. PubMed ID: 34142341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma.
    Inda MM; Bonavia R; Mukasa A; Narita Y; Sah DW; Vandenberg S; Brennan C; Johns TG; Bachoo R; Hadwiger P; Tan P; Depinho RA; Cavenee W; Furnari F
    Genes Dev; 2010 Aug; 24(16):1731-45. PubMed ID: 20713517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGFR and PDGFRA co-expression and heterodimerization in glioblastoma tumor sphere lines.
    Chakravarty D; Pedraza AM; Cotari J; Liu AH; Punko D; Kokroo A; Huse JT; Altan-Bonnet G; Brennan CW
    Sci Rep; 2017 Aug; 7(1):9043. PubMed ID: 28831081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.
    Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X
    J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors.
    Lokker NA; Sullivan CM; Hollenbach SJ; Israel MA; Giese NA
    Cancer Res; 2002 Jul; 62(13):3729-35. PubMed ID: 12097282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of protein tyrosine phosphorylation reduce the proliferation of two human glioma cell lines.
    Oude Weernink PA; Verheul E; Kerkhof E; van Veelen CW; Rijksen G
    Neurosurgery; 1996 Jan; 38(1):108-13; discussion 113-4. PubMed ID: 8747958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Phenotypes of Proliferating Glioblastoma Cells Reside on a Single Axis of Variation.
    Wang L; Babikir H; Müller S; Yagnik G; Shamardani K; Catalan F; Kohanbash G; Alvarado B; Di Lullo E; Kriegstein A; Shah S; Wadhwa H; Chang SM; Phillips JJ; Aghi MK; Diaz AA
    Cancer Discov; 2019 Dec; 9(12):1708-1719. PubMed ID: 31554641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. YAP/TAZ Transcriptional Coactivators Create Therapeutic Vulnerability to Verteporfin in EGFR-mutant Glioblastoma.
    Vigneswaran K; Boyd NH; Oh SY; Lallani S; Boucher A; Neill SG; Olson JJ; Read RD
    Clin Cancer Res; 2021 Mar; 27(5):1553-1569. PubMed ID: 33172899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PDGF Family Expression in Glioblastoma Multiforme: Data Compilation from Ivy Glioblastoma Atlas Project Database.
    Cantanhede IG; de Oliveira JRM
    Sci Rep; 2017 Nov; 7(1):15271. PubMed ID: 29127351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic activation of wild-type epidermal growth factor receptor and loss of Cdkn2a cause mouse glioblastoma formation.
    Acquaviva J; Jun HJ; Lessard J; Ruiz R; Zhu H; Donovan M; Woolfenden S; Boskovitz A; Raval A; Bronson RT; Pfannl R; Whittaker CA; Housman DE; Charest A
    Cancer Res; 2011 Dec; 71(23):7198-206. PubMed ID: 21987724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-derived growth factor in glioblastoma-driver or biomarker?
    Westermark B
    Ups J Med Sci; 2014 Nov; 119(4):298-305. PubMed ID: 25342206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.